According to Redhill Biopharma's latest financial reports the company's total assets are $35.03 M. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | $0.15 B | -12.32% |
2021-12-31 | $0.18 B | 0.53% |
2020-12-31 | $0.18 B | 143.24% |
2019-12-31 | $74.09 M | 18.73% |
2018-12-31 | $62.41 M | 8.84% |
2017-12-31 | $57.34 M | -22.73% |
2016-12-31 | $74.21 M | 11.05% |
2015-12-31 | $66.82 M | 131.59% |
2014-12-31 | $28.85 M | 101.23% |
2013-12-31 | $14.34 M | -28.64% |
2012-12-31 | $20.09 M | -0.45% |
2011-12-31 | $20.18 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Sanofi SNY | $139.81 B | 398,952.43% | ๐ซ๐ท France |
Merck MRK | $106.67 B | 304,363.85% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $75.11 B | 214,283.08% | ๐ฌ๐ง UK |
Teva Pharmaceutical Industries TEVA | $43.47 B | 123,994.53% | ๐ฎ๐ฑ Israel |
Taro Pharmaceutical TARO | $2.16 B | 6,073.99% | ๐ฎ๐ฑ Israel |